Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mancini

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Annali Dell'Istituto Superiore Di Sanita|June 20, 2018
The Italian National External Quality Assessment Program in Cytogenetics: 4 years of activity (2013-2016) following the introduction of poor performance criteriaMaria Chiara de Stefano, Giovanna Floridia, Federica Censi, et al.
Blood|February 14, 2012
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expressionGiuseppe Zardo, Alberto Ciolfi, Laura Vian, et al.
Optics Express|July 14, 2016
Measuring absolute frequencies beyond the GPS limit via long-haul optical frequency disseminationCecilia Clivati, Giacomo Cappellini, Lorenzo F Livi, et al.
Computational Intelligence and Neuroscience|October 23, 2018
Neurophysiological Responses to Different Product ExperiencesEnrica Modica, Giulia Cartocci, Dario Rossi, et al.
American Journal of Hematology|March 22, 2022
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trialGiovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, et al.
Hematological Oncology|December 10, 2015
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemiaRoberto Latagliata, Ida Carmosino, Federico Vozella, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Digital Health|August 7, 2023
A predictive decision support system for coronavirus disease 2019 response management and medical logistic planningSofiane Atek, Filippo Bianchini, Corrado De Vito, et al.
American Journal of Hematology|September 29, 2011
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion geneLoredana Elia, Sara Grammatico, Francesca Paoloni, et al.
Cancer Research|September 5, 2006
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemiaGiuseppe Cimino, Francesco Lo-Coco, Susanna Fenu, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Annali Dell'Istituto Superiore Di Sanita|June 20, 2018
The Italian National External Quality Assessment Program in Cytogenetics: 4 years of activity (2013-2016) following the introduction of poor performance criteriaMaria Chiara de Stefano, Giovanna Floridia, Federica Censi, et al.
Blood|February 14, 2012
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expressionGiuseppe Zardo, Alberto Ciolfi, Laura Vian, et al.
Optics Express|July 14, 2016
Measuring absolute frequencies beyond the GPS limit via long-haul optical frequency disseminationCecilia Clivati, Giacomo Cappellini, Lorenzo F Livi, et al.
Computational Intelligence and Neuroscience|October 23, 2018
Neurophysiological Responses to Different Product ExperiencesEnrica Modica, Giulia Cartocci, Dario Rossi, et al.
American Journal of Hematology|March 22, 2022
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trialGiovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, et al.
Hematological Oncology|December 10, 2015
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemiaRoberto Latagliata, Ida Carmosino, Federico Vozella, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Digital Health|August 7, 2023
A predictive decision support system for coronavirus disease 2019 response management and medical logistic planningSofiane Atek, Filippo Bianchini, Corrado De Vito, et al.
American Journal of Hematology|September 29, 2011
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion geneLoredana Elia, Sara Grammatico, Francesca Paoloni, et al.
Cancer Research|September 5, 2006
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemiaGiuseppe Cimino, Francesco Lo-Coco, Susanna Fenu, et al.
Pageof 12